1,7-phenanthroline has been researched along with cyclin d1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Qawasmeh, RA; Cukier, IH; Huesca, M; Jin, H; Khine, AA; Lee, Y; Lock, LS; Peralta, R; Viau, S; Wright, J; Young, A | 1 |
| Chung, HJ; Kim, EH; Kim, S; Lee, SK; Min, HY; Park, EJ | 1 |
2 other study(ies) available for 1,7-phenanthroline and cyclin d1
| Article | Year |
|---|---|
A novel small molecule with potent anticancer activity inhibits cell growth by modulating intracellular labile zinc homeostasis.
Topics: Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Cycle; Cell Division; Cell Proliferation; Colonic Neoplasms; Cyclin D1; DNA Primers; Electrophoresis, Polyacrylamide Gel; Flow Cytometry; Homeostasis; HT29 Cells; Humans; Imidazoles; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Phenanthrolines; Polymerase Chain Reaction; Promoter Regions, Genetic; Sp1 Transcription Factor; Up-Regulation; Zinc | 2009 |
Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Indoles; Mice; Mice, Inbred BALB C; Phenanthrolines; Signal Transduction; Tumor Necrosis Factor-alpha; Wnt Proteins | 2010 |